http://orcid.org/0000-0003-2057-3423
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Li Lv, Yonghui Shi, Junyan Wu & Guocheng Li. (2021) Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting. International Journal of Nanomedicine 16, pages 1487-1508.
Read now
Read now
Sai Kiran S. S. Pindiprolu, Pavan Kumar Chintamaneni, Praveen T. Krishnamurthy & Kinnera Ratna Sree Ganapathineedi. (2019) Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. Drug Development and Industrial Pharmacy 45:2, pages 304-313.
Read now
Read now
Adil M. Allahverdiyev, Etkin Parlar, Sahar Dinparvar, Melahat Bagirova & Emrah Şefik Abamor. (2018) Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 755-762.
Read now
Read now
Atmaram Pawar, Srishti Singh, S. Rajalakshmi, Karimunnisa Shaikh & C. Bothiraja. (2018) Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 347-361.
Read now
Read now
Articles from other publishers (19)
Refaat A. Eid, Muhammad Alaa Edeen, Eslam M. Shedid, Al Shaimaa S. Kamal, Mona M. Warda, Farag Mamdouh, Sohila A. Khedr, Mohamed A. Soltan, Hee Won Jeon, Mohamed Samir A. Zaki & Bonglee Kim. (2023) Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance. International Journal of Molecular Sciences 24:2, pages 1786.
Crossref
Crossref
Poonam Banthia, Lokesh Gambhir, Dhiraj Daga, Asha Sharma, Neha Kapoor, R. D. Agarwal & Gaurav Sharma. (2022) Phytogenic synthesis of metallic nanoparticles: application for breast cancer nanomedicine. Vegetos 36:1, pages 10-19.
Crossref
Crossref
Pavan Kumar Chintamaneni, Dasari Nagasen, Katta Chanti Babu, Atul Mourya, Jitender Madan, Dadi A. Srinivasarao, R.K. Ramachandra, P. Madhuri Santhoshi & Sai Kiran S.S. Pindiprolu. (2022) Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art. Journal of Controlled Release 352, pages 652-672.
Crossref
Crossref
Vaishnavi Gadi, Dhruv Gupta & Saritha Shetty. (2022) Emerging potentials of nanotherapeutics in breast cancer microenvironment targeting. OpenNano 8, pages 100101.
Crossref
Crossref
Taniya Saha & Kiven Erique Lukong. (2022) Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. Frontiers in Oncology 12.
Crossref
Crossref
Poonam Banthia, Lokesh Gambhir, Asha Sharma, Dhiraj Daga, Neha Kapoor, Rishabh Chaudhary & Gaurav Sharma. (2022) Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech 12:3.
Crossref
Crossref
Prachi Ghoderao, Sanjay Sahare, Anjali A. Kulkarni & Tejashree Bhave. 2022. Paclitaxel. Paclitaxel
309
331
.
Kai Song & Maryam Farzaneh. (2021) Signaling pathways governing breast cancer stem cells behavior. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
Mohammad Azam Ansari, Muthu Thiruvengadam, Zeba Farooqui, Govindaswamy Rajakumar, Qazi Mohammad Sajid Jamal, Mohammad A. Alzohairy, Ahmad Almatroudi, Mohammad N. Alomary, Ill-Min Chung & Ebtesam Abdullah Al-Suhaimi. (2021) Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer. Seminars in Cancer Biology 69, pages 109-128.
Crossref
Crossref
Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, V. V. V. Ravi Kiran Ammu & Kusuma Kumari Garikapati. 2021. Cancer Nanotheranostics. Cancer Nanotheranostics
175
200
.
Vikas Jain, Hitesh Kumar, Haritha V. Anod, Pallavi Chand, N. Vishal Gupta, Surajit Dey & Siddharth S. Kesharwani. (2020) A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. Journal of Controlled Release 326, pages 628-647.
Crossref
Crossref
Qi-Yao Wei, Yan-Ming Xu & Andy T. Y. Lau. (2020) Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies. Cancers 12:10, pages 2783.
Crossref
Crossref
Mamta Kumari, Praveen Thaggikuppe Krishnamurthy & Piyong Sola. (2020) Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer. Current Cancer Drug Targets 20:8, pages 559-572.
Crossref
Crossref
Sai Kiran SS Pindiprolu, Praveen T Krishnamurthy, Venkata Rao Ghanta & Pavan Kumar Chintamaneni. (2020) Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer. Nanomedicine 15:16, pages 1551-1565.
Crossref
Crossref
Pravin S. Uttekar, Sameer H. Lakade, Vijay K. Beldar & Minal T. Harde. (2019) Facile synthesis of multi‐walled carbon nanotube via folic acid grafted nanoparticle for precise delivery of doxorubicin. IET Nanobiotechnology 13:7, pages 688-696.
Crossref
Crossref
Mantosh Kumar Singh, Sai Kiran S. S. Pindiprolu, Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele & G. N. K. Ganesh. (2019)
Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer:
in vitro
studies
. RSC Advances 9:43, pages 24987-24994.
Crossref
Crossref
Sai Harshini Pindiprolu & Sai Kiran S.S. Pindiprolu. (2019) CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma. Medical Hypotheses 129, pages 109241.
Crossref
Crossref
Pal Patel, Nikita Meghani, Krupa Kansara & Ashutosh Kumar. (2019) Nanotherapeutics for the Treatment of Cancer and Arthritis. Current Drug Metabolism 20:6, pages 430-445.
Crossref
Crossref
Sai Kiran S. S. Pindiprolu, Praveen T. Krishnamurthy & Pavan Kumar Chintamaneni. (2018) Pharmacological targets of breast cancer stem cells: a review. Naunyn-Schmiedeberg's Archives of Pharmacology 391:5, pages 463-479.
Crossref
Crossref